Compagnie Lombard Odier SCmA - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q4 2016$0870.0%0.00%
Q3 2016$0870.0%0.00%
Q2 2016$0870.0%0.00%
Q1 2016$0
-100.0%
870.0%0.00%
Q4 2015$1,0000.0%870.0%0.00%
Q3 2015$1,0000.0%870.0%0.00%
Q2 2015$1,0000.0%870.0%0.00%
Q1 2015$1,0000.0%870.0%0.00%
Q4 2014$1,0000.0%870.0%0.00%
Q3 2014$1,0000.0%870.0%0.00%
Q2 2014$1,0000.0%870.0%0.00%
Q1 2014$1,0000.0%870.0%0.00%
Q4 2013$1,000870.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q1 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,918,722$6,006,0004.90%
Tamarack Advisers, LP 4,400,000$13,882,0002.18%
AlphaOne Investment Services, LLC 580,965$1,824,0000.60%
CLOUGH CAPITAL PARTNERS L P 3,061,064$9,581,0000.50%
Rock Springs Capital Management LP 1,200,000$3,751,0000.24%
TURNER INVESTMENTS LLC 150,000$470,0000.16%
WESTFIELD CAPITAL MANAGEMENT CO LP 5,397,007$16,893,0000.14%
SABBY MANAGEMENT, LLC 484,505$1,521,0000.06%
PUTNAM INVESTMENTS LLC 3,673,622$11,536,0000.03%
ARDSLEY ADVISORY PARTNERS LP 28,900$90,0000.01%
View complete list of CARDIOME PHARMA CORP shareholders